Literature DB >> 27825565

CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.

Isabelle Duroux-Richard1, Carine Giovannangeli2, Florence Apparailly3.   

Abstract

Entities:  

Keywords:  CRISPR-Cas; Genome editing; Rheumatism

Mesh：

Year:  2016        PMID： 27825565     DOI： 10.1016/j.jbspin.2016.09.012

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Lubricin: A Principal Modulator of the Psychoneuroendocrine - Osteoimmune Interactome - Implications for Novel Treatments of Osteoarthritic Pathologies.

Authors:  Allen Khakshooy; Nicole Balenton; Francesco Chiappelli
Journal:  Bioinformation       Date:  2017-10-31

2.  SiRNA-Mediated RRM2 Gene Silencing Combined with Cisplatin in the Treatment of Epithelial Ovarian Cancer In Vivo: An Experimental Study of Nude Mice.

Authors:  Ting Xue; Liming Wang; Yong Li; Hao Song; Huijun Chu; Hongjuan Yang; Ailian Guo; Jinwen Jiao
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.